China targets 25 share global first class drugs new 5 year plan

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 24 Sept, 12:07 UTC

China is aiming to account for at least 25% of first-in-class drugs as part of a five-year push to cement its emerging status as a hotbed for innovative R&D.

science

Sources

• T2China targets 25 share global first class drugs new 5 year planFierce Biotech / Fierce Healthcare / MedCity / GEN24 Sept, 12:07